![Adolf Hoess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adolf Hoess
Directeur Général chez
Affimed NV Niederlassung Deutschland
Profil
Adolf Hoess is currently the Chief Executive Officer at Affimed GmbH and SomaServe Ltd. He is also the Chairman-Management Board at Affimed NV Niederlassung Deutschland.
Previously, he held the position of Chief Executive Officer & Director at Affimed NV from 2010 to 2024.
He was also the Chief Executive Officer at Jenowis AG and Director at Amphivena Therapeutics, Inc. Dr. Hoess has a background in academia, having worked as a Principal at Harvard University in 1993.
He also served as the Vice President-Licensing & Business Development at MorphoSys AG and General Manager & VP-Molecular Division at Carl Zeiss Jena GmbH.
Additionally, he held the position of Chief Commercial Officer at Shire Orphan Therapies GmbH.
Dr. Hoess obtained his doctorate degrees from Technische Universität München in 1997 and Ludwig-Maximilians-Universität München in 1991.
Postes actifs de Adolf Hoess
| Sociétés | Poste | Début |
|---|---|---|
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Directeur Général | - |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Directeur Général | 01/09/2011 |
SomaServe Ltd.
 SomaServe Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | 01/10/2024 |
Anciens postes connus de Adolf Hoess
| Sociétés | Poste | Fin |
|---|---|---|
| AFFIMED N.V. | Directeur Général | 15/01/2024 |
Carl Zeiss Jena GmbH
 Carl Zeiss Jena GmbH Medical SpecialtiesHealth Technology Manufactures lenses for health care, photography, projecting and research services | Corporate Officer/Principal | 01/01/2002 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1993 |
Jenowis AG | Directeur Général | - |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Directeur/Membre du Conseil | - |
Formation de Adolf Hoess
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Carl Zeiss Jena GmbH
Carl Zeiss Jena GmbH Medical SpecialtiesHealth Technology Manufactures lenses for health care, photography, projecting and research services | Health Technology |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
Jenowis AG | |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
SomaServe Ltd.
SomaServe Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
